Carson Wealth (CWM LLC)
HOWL icon

Carson Wealth (CWM LLC)’s Werewolf Therapeutics HOWL Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio HOWL Stock Details HOWL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,569
Closed -$3K – 5473
2025
Q3 		$3K Sell
1,569
-6,879
-81% -$9.42K ﹤0.01% 4899
2025
Q2 		$9K Buy
8,448
+1,663
+25% +$1.71K ﹤0.01% 4355
2025
Q1 		$7K Buy
6,785
+6,478
+2,110% +$8.48K ﹤0.01% 4285
2024
Q4 		$0 Buy
307
+115
+60% +$234 ﹤0.01% 5007
2024
Q3 		$0 Buy
+192
New +$437 ﹤0.01% 4955

Other funds holding HOWL

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DF
DC Funds Mclean, Virginia $1.49M AUM 18.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Carson Wealth (CWM LLC)'s HOWL Position: Q4 2025 in Review

Carson Wealth (CWM LLC) sold out of Werewolf Therapeutics (HOWL) in Q4 2025, closing a stake of 1,569 shares — an estimated $3K sold.

Carson Wealth (CWM LLC) first reported a position in HOWL in Q3 2024 and held it in 5 quarters. The position peaked at $9K in Q2 2025. 51 funds tracked by Wall St. Rank hold HOWL as of Q4 2025.

  • Carson Wealth (CWM LLC) reported no remaining Werewolf Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 1,569 Werewolf Therapeutics shares in Q4 2025, an estimated $3K.
  • Carson Wealth (CWM LLC) first reported a position in Werewolf Therapeutics in Q3 2024 and held it in 5 quarters.
  • Carson Wealth (CWM LLC)'s Werewolf Therapeutics position peaked at $9K in Q2 2025.
  • 51 funds tracked by Wall St. Rank held Werewolf Therapeutics as of Q4 2025.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q4 2025, filed 26 Jan 2026.